Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk
Jennifer L. Caswell‐Jin(Stanford University), Allison W. Kurian(Stanford University), Alexandra Lebensohn(Stanford University), Kerry Kingham(Cargill (Netherlands)), Evan Hall(Stanford University), Tanya Gupta(Stanford University), Rachel Koff(Stanford University), Peter Levonian(Stanford University), Iva Petrovchich(Stanford University), James M. Ford(Palo Alto University), Nicolette M. Chun(Stanford University), Meredith Mills(Cargill (Netherlands))
Cited by 217
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
|Clinical Cancer Research|2016|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660